Merck & Co., Inc. news

   Watch this stock
Showing stories 1 - 10 of about 154   

Articles published

MRK 58.96 +0.47 (0.80%)
price chart
Trade of the Day: MRK Stock Fires Off Triple Buy Signals
Merck & Co., Inc. (NYSE:MRK) - This is one of the world's largest drug manufacturers, and recent acquisitions have added to its position in niche markets.
Merck & Co. Inc. (NYSE:MRK) Partners With MPP to help Developing Countries ...
Merck & Co. Inc. (NYSE:MRK), which is the second biggest drug maker in United States, has announced that it has made an agreement with the MPP (medicine patent pool) for its HIV treatment.
5 Things Merck & Co., Inc.'s Management Wants You to Know
Pharmaceutical giant Merck (NYSE: MRK ) offers a number of promising new drug candidates, but unfortunately for investors it delivered another highly forgettable quarter this past week.
Merck & Co., Inc. Collaborates With MPP To Increase Access To Its HIV Drug In ...
Merck & Co., Inc. (NYSE:MRK), the second-largest US drug maker, has announced an agreement with the Medicines Patent Pool (MPP) for its HIV drug, raltegravir, in its efforts to expedite the process of developing low-priced pediatric formulations for ...
New Jersey Drugmaker Grants Free License to HIV Medicine for Children  NBC 10 Philadelphia
Merck & Co., Inc. Collaborates With NGM To Develop Novel Biologic Therapeutics
Merck & Co., Inc. (NYSE:MRK) announced Monday that it has entered into a multi-year collaboration agreement with NGM Biopharmaceuticals Inc., a privately held biotechnology company, to research, develop, as well as commercialize innovative biologic ...
Merck's Research Man Saved Biotech Deal With Juicy Pitch  Bloomberg
NGM and Merck Announce Broad Strategic Collaboration to Discover, Develop ...  MarketWatch
One Put, One Call Option To Know About for Merck & Co.
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Merck & Co., Inc (NYSE: MRK). So this week we highlight one interesting put contract, and one interesting call contract, from the ...
Merck & Co. Inc. (MRK) Closes 0.8% Up on the Day for February 26
Merck & Co. Inc. currently has a total float of 2.85 billion shares and moves 9.91 million a day, on average. The stock opened at $58.66 on February 26 and traded between a low of $58.66 and a high of $59.15.
Merck & Co. Inc. (NYSE:MRK) Tights Its Shoes To Present New Data of ...
Merck & Co. Inc. (NYSE:MRK) [Trend Analysis] reported that new data from two examinations of the firm's cardiovascular medicines would be presented at the 2015 American College of Cardiology Annual Scientific Sessions, March 14-16 in San Diego.
Analyst Rating Update on Merck & Co., Inc.  Stafford Daily
Morning Movers: The TJX Companies (NYSE:TJX), ICICI Bank (NYSE:IBN ...  Property Mentor
What Should You Do With Merck In 2015? (MRK)
Merck & Co. (NYSE:MRK) last week announced rather disappointing quarterly and full year 2014 results. The results once again highlighted the loss of revenue due to the patent cliff.
Merck & Co., Inc. Price Target Update  Stafford Daily
Company Watch : Merck & Co. Inc. (NYSE:MRK)  Street Report
Merck & Co. Inc
Merck & Co. Inc. (NYSE:MRK), which is the second biggest drug maker in United States, has announced that it has made an agreement with the MPP (medicine patent pool) for its HIV treatment.